Exact Sciences (EXAS) Cash & Current Investments (2016 - 2025)
Exact Sciences (EXAS) has disclosed Cash & Current Investments for 16 consecutive years, with $964.7 million as the latest value for Q4 2025.
- Quarterly Cash & Current Investments fell 7.06% to $964.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $964.7 million through Dec 2025, down 7.06% year-over-year, with the annual reading at $964.7 million for FY2025, 7.06% down from the prior year.
- Cash & Current Investments for Q4 2025 was $964.7 million at Exact Sciences, down from $1.0 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $1.4 billion in Q1 2021, with the low at $213.0 million in Q2 2025.
- Average Cash & Current Investments over 5 years is $852.6 million, with a median of $797.3 million recorded in 2022.
- The sharpest move saw Cash & Current Investments soared 39.04% in 2024, then plummeted 77.5% in 2025.
- Over 5 years, Cash & Current Investments stood at $1.0 billion in 2021, then tumbled by 38.66% to $632.1 million in 2022, then grew by 23.03% to $777.6 million in 2023, then surged by 33.48% to $1.0 billion in 2024, then decreased by 7.06% to $964.7 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods came in at $964.7 million, $1.0 billion, and $213.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.